Since the advent of immune-checkpoint blockade, T-cells gained much attention in regard to their anti-cancer properties. It has also become obvious that alterations of the metabolic landscape impact T-cell functionality. Yet, an in-depth understanding of metabolic determinants that control phenotypes is only starting to arise. A recent metabolic screen (unpublished) performed in the Brenner lab has uncovered new regulators that impact the immune response of cytotoxic T-cells. These identified targets will be mechanistically characterised to understand their role in the immunological circuit. In addition to ex vivo T-cell assays, genetically engineered mouse models will be employed.
|Acronym||CANBIO2 (Sarah Alhamouieh)|
|Effective start/end date||1/12/23 → 30/11/27|
- FNR - Fonds National de la Recherche: €170,000.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.